Buy-out deal sparks 111% rally 🚀

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Welcome back and Happy Monday! It's May 15th. I hope you had a great weekend. Here's what moved the market today: Markets 📈 Stocks indexes briefly slipped into the red after today's opening bell, but they quickly recovered and managed to close the day higher. The Dow [+0.1%], S&P 500 [+0.3%] and Nasdaq [+0.6%], notched fractional gains, while the small-cap Russell 2K [+1.1%] rallied by more than a point. This weekend, Treasury Sect. Janet Yellen said debt ceiling negotiations were making progress and could result in the deal, which most likely provided the catalyst for today's move higher. Sponsored [Shark Tank's Kevin O'Leary is Putting His Money Here]( If you have ever watched Shark Tank, you know Kevin O'Leary (Mr. Wonderful) is very protective of his money. In fact, he expects to multiply his investments by at least 10x when he gets in... and the company Bryan Perry discusses in this video is exactly what Mr. Wonderful looks for. In fact, not only did Kevin invest his money in it, he also put his own personal team to work in the company. Bryan calls this opportunity part of "the greatest wealth transfer in history." [To learn more, click here now to watch this video.]( Today's Market-Moving News 🔎 💵 The Latest on Debt Ceiling Talks Pres. Biden said today that the next meeting with congressional leaders will come on Tuesday. When asked if there were updates regarding talks with House Republicans, Biden said, "no," and noted that the two sides remain "far apart." However, the president also added that he would like to get a deal in place by this weekend. Today's Top Winners and Losers 🔥 Exela Technologies [XELA] $3.08 (-38.4%) Exela Technologies fell after executing a 1-for-200 reverse stock split in Friday's after-market. Larimar Therapeutics [LRMR] $3.59 (-29.0%) Larimar Therapeutics fell after preliminary top-line data from Phase 2 trials of CTI-1601 in Friedreich's ataxia patients missed the market's expectations. Impel Pharmaceuticals [IMPL ://elitetra.de/L2Ic ] $1.15 (-24.3%) After Friday's close, a Form 4 filing revealed Impel Pharma's CFO Michael Kalb had been awarded more than 220,000 in stock options and restricted stock units. NeoGames [NGMS] $27.17 (+111.6%) On Sunday, NeoGames agreed to be acquired by Australia's Aristocrat Leisure in an all-cash deal valued at $1.2 billion. Under the terms of the agreement, NGMS shareholders will receive $29.50 for each common share, a 129% premium from the stock's Friday closing price. Ohmyhome [OMH] $30.88 (+67.2%) Ohmyhome rallied after announcing a new investment and expansion push into the Philippines market. The new partnership provides access to the massive Philippines real estate market, including over 80,000 properties by more than 150 developers Sarepta Therapeutics [SRPT] $157.19 (+30.7%) An FDA advisory committee voted 8 to 6 in favor of accelerated approval for Sarepta's SRP-9001 in Duchenne muscular dystrophy patients. Although the panel's vote isn't binding, the FDA usually follows the advice of its experts, so the ruling greatly improved the drug's chances of fast-track approval. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... Text ELITE to 47121 to get our watchlists sent directly to your phone! You can also text CLOSE to 47121 to get the Closing Bell Roundup, too! *Standard message/carrier rates may apply. © Elite Trade Media LLC, 2023. All rights reserved. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Bots click here]( 1969 Alafaya Trail Suite #247 Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](